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Abstract
Introduction. Few oral antidiabetic drugs have been evaluated for their reproductive complication. This study 
aimed to evaluate the effect of metformin, pioglitazone and sitagliptin on the structure of male reproductive 
system through an immunohistopathological study.
Material and methods. Sprague-Dawley male rats were injected with streptozotocin. The diabetic rats were 
divided into four groups (n = 8/each group); diabetic control, metformin-, pioglitazone- and sitagliptin-tre-
ated groups in addition to a normal control group (n = 8). At the end of the experiment, blood samples were 
collected for biochemical assessment. Testis, epididymis and seminal vesicle were dissected and processed for 
histopathological examination using routine and immune-staining.
Results. All drugs significantly (p < 0.05) decreased fasting blood glucose, glycated hemoglobin, total chole-
sterol, triglycerides and malondialdehyde compared to the diabetic control group. Metformin has induced the 
least pathologic changes on the structure of the testis, epididymis and seminal vesicle among the studied drugs. 
Metformin succeeded to restore weights of testis, epididymis and seminal vesicle as well as testosterone hormone 
level back to values of the NC group while the pioglitazone and sitagliptin failed to do that. A significant reduction 
(p < 0.05) in testicular ERa and ERb immunoexpression of pioglitazone-treated group as well as suppression 
of ERb and AR immunoreactivity in in epididymus and seminal vesicles of pioglitazone- and sitagliptin-treated 
rats were observed compared to the control animals.
Conclusions. Histological structure as well ER and AR expression in the system organs were negatively and 
significantly affected with all studied drugs. Metformin has the least effect on the structure of the studied male 
reproductive organs. Thus, pioglitazone and sitagliptin treatment should be avoided in young male diabetic 
patients.  (Folia Histochemica et Cytobiologica 2015, Vol. 53, No. 1, 35–48)
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Introduction
Diabetes mellitus (DM) is a metabolic disorder cha-
racterized mainly by hyperglycemia and leading to 
complications in many integral body organs including 
reproductive system [1, 2]. The reported testicular 
changes of streptozotocin (STZ)-induced diabetic 
rats are not caused by a direct effect of STZ, but 
by diabetes itself [3]. Therefore, STZ-induced dia- 
betes in rats is used as a model for studying effects 
of diabetes on various body organs [4, 5]. A closer 
look into fertility rates of modern societies reveals 
that the increased incidence of DM has been closely 
associated with falling birth rates and fertility [6, 7]. 
This is due to a disturbing increase of diabetic men 
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in reproductive age as well as the multiple molecular 
mechanisms and pathways are affected by DM with dra-
matic consequences to male reproductive function [8]. 
Several reports also demonstrated that DM is asso-
ciated with hormonal deregulation, particularly of sex 
steroids hormones [9, 10].
Metformin (dimethylbiguanide) is a drug that 
reduces blood glucose level and improves the glucose 
tolerance without altering the plasma insulin profile 
[11, 12]. It has been used clinically for over 50 years 
and is recognized as the ﬁrst-line drug of choice for the 
treatment of patients with type 2 diabetes (T2D) [13].
Sitagliptin was introduced into the diabetes the-
rapeutic armamentarium in 2006. Since that date 
the use of dipeptidyl peptidase-4 (DPP-4) inhibitors 
for the management of type 2 diabetic patients has 
increased. Continued assessment of adverse events 
of sitagliptin reported from clinical trials and post-
-marketing environment is ongoing [14]. Pioglitazone 
(a thiazolidinedione) acts as an insulin sensitizer and 
is used for treating type 2 diabetes [15]. It improves 
insulin sensitivity; impair glucose tolerance and dys-
lipidemia [16]. 
Androgens are steroid hormones primarily 
involved in the establishment of sexual maturation at 
puberty, and in maintenance of the male reproductive 
function, spermatogenesis and sexual behavior during 
adult life [17]. It is well established that androgen 
receptors (AR) are expressed widely throughout 
the developing male reproductive system [18]. Many 
studies have proved that not only androgens have im-
portant functions in the adult male reproductive tract, 
but also estrogen and its receptors are “essential” for 
normal fertility in the male [19–20]. 
Only few antidiabetic drugs have been evaluated 
for their reproductive complications [21]. Therefore, 
this study was designed to evaluate effects of the 
commonly used oral antidiabetics; metformin, pio-
glitazone and sitagliptin; on the male reproductive 
system (testis, epididymis and seminal vesicle) in 
STZ-induced diabetic rats through immunohistopa-
thological study. The study used both androgen and 
estrogen receptors as indicators of the integrity of the 
male reproductive system.
Material and methods
Animals. This experimental study was approved by the King 
Abdulaziz University Research Ethics Committee (KAU-
-REC) and adhered to the international guidelines for use 
of experimental animals. Sprague-Dawley male rats aged 
three months and weighing 250–300 g were recruited from 
King Fahd Research Center, KAU, SA, were acclimated 
for 6 days before use and were housed in plastic cages in an 
air-conditioned room at 24°C in a 12 h light–dark cycle with 
food and water available ad libitum [22].
Induction of diabetes mellitus and administration of 
drugs. Thirty five rats were injected intraperitoneally (ip) 
with low dose of STZ (35 mg/kg) as was described by Srini-
vasan et al. [23]. In one week after STZ injection, blood was 
drawn from the tail vein and blood glucose was measured. 
Rats with 16.65 mmol/L (300 mg/dL) non-fasting blood 
glucose level were considered to be diabetic rats (n = 32). 
They were randomly allocated to four groups (n = 8): dia-
betic control (DC) group that received no treatment and 
three drug-treated groups receiving metformin at the dose 
100 mg/kg/day) according to Sun et al. [24], pioglitazone 
(20 mg/kg/day) according to Ding et al. [15] and sitagliptin 
(30 mg/kg/day) according to Chen et al. [25]. All drugs and 
chemicals were purchased from Sigma-Aldrich Corp. (St. 
Louis, MO, USA). Drugs were dissolved in distilled water 
and given in a volume of 1 mL for 6 weeks by oral gavage. 
Five rats designated as normal control (NC) group were 
given vehicle citrate buffer (pH 4.4) in a volume of 1 mL/kg, 
ip and were fed standard chow [23]. 
Measurements of body weight (BW) and blood parameters. 
Rats’ body weight was measured initially, weekly and at the 
end of the study. A blood sample (3 mL) was collected after 
an overnight fast at the end of the study from each rat by capil-
lary tubes via the retroorbital sinus under light anesthesia by 
ether. Each sample was divided into two parts. The first part 
(2.5 mL) was placed in a plain tube for separation of serum 
which was stored at −80°C until measurement of the levels 
of fasting blood glucose (FBS), total cholesterol (TC), tri-
glycerides (TG), malondialdehyde (MDA) and testosterone 
by using commercially available colorimetric kits. The latter 
was determined in duplicate using the Testosterone Enzyme 
Immunoassay kit (Assay Design Inc., Ann Arbour, USA) 
according to the manufacturer’s instructions. The detection 
limit for this assay was 3.82 pg/mL; cross reactivity with 
corticosteroid and other androgens was minimal (< 1%). 
Serum insulin level was measured by using a rat insulin 
ELISA assay kit. The second part (0.5 mL) was placed in 
an EDTA tube for measurement of glycated hemoglobin 
(HbA1c). All kits were purchased from Biocompare (South 
San Francisco, CA, USA) and measurements were done in 
accordance with the manufacturer’s protocol [22, 26]. 
Tissue sampling. Animals were anesthetized with diethyl 
ether and sacrificed by cervical dislocation then perfused 
with 10% neutral-buffered formalin. Testis, epididymis 
and seminal vesicle were dissected out, weighted, trim-
med, fixed in Bouin overnight then processed to obtain 
paraffin blocks. Serial paraffin sections were cut into 
5 µm thickness and stained with hematoxylin and eosin 
(H & E) and Masson trichrome (MT) according to Drury 
and Wallington [27]. 
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Immunohistochemical methods. Paraffin sections were 
immunostained using an avidin–biotin technique according 
to Nie et al. [28]. Paraffin sections on positive slides were 
immunostained using an avidin–biotin technique. Slides 
were deparaffinized, rehydrated, rinsed in tap water, and 
embedded in 3% H2O for 10 min to block endogenous 
peroxidase. Sections were immersed in an antigen retrieval 
solution (10 mmol/L sodium citrate buffer, pH 6) and subjec-
ted to heat-induced antigen retrieval for 20 min in a micro-
wave. Nonspecific protein binding was blocked by blocking 
solution (PBS + 10% normal goat serum). The slides were 
incubated for 30 min with the diluted primary antibodies. 
Estrogen receptor alpha (ERa) was immunolocalized in the 
tissue using a mouse monoclonal antibody (NCL-ER-6F11), 
which is raised to the N-terminal (A/B) region of the human 
ERa at a 1:1,000 dilution according to that of Attia and 
Elmansy [29]. The monoclonal antibodies and diaminoben-
zidine were obtained from Sigma-Aldrich Corp. (St. Louis, 
MO, USA). Estrogen receptor beta (ERb) was localized 
using rabbit polyclonal antipeptide IgGs raised against 
a specific peptide located in the D region of rat ERb (Dako, 
Glostrup, Denmark) at a dilution 1:100 to 1:250 as described 
in Saunders et al. [30]. Androgen receptor (AR) was locali-
zed using rabbit anti-AR (N-20, Santa Cruz Biotechnology, 
CA, USA), which was diluted 1:250 in phosphate-buffered 
saline and 0.25% bovine serum albumin and maintained at 
room temperature overnight. Following primary antibody 
incubation, sections were incubated with goat anti-rabbit 
biotinylated secondary antibody followed by an avidin–biotin 
horseradish peroxidase complex (Dako). Drops of streptavi-
din peroxidase were added to the slide, left for 20 min, and 
then washed with PBS for 5 min. Diaminobenzidine was 
added to slides as a chromogen, after which the slides were 
washed with distilled water. Finally, the slides were stained 
with Mayer’s hematoxylin, dehydrated, and cleared in xylene. 
For the negative control slides, the specific primary antibody 
was replaced by PBS. Monoclonal mouse anti-antibody kits 
and diaminobenzidine were obtained from Sigma-Aldrich. 
Sections incubated without the primary antibody but with PBS 
were used as negative controls for color development on the 
same slide. All positive reactivity was noted as predominantly 
nuclear and cytoplasmic brown staining.
An Olympus Microscope BX-51 with a digital camera 
connected to a computer was used for photographing. The 
Pro Plus image analysis software version 6.0 was used for 
the measurement of area percentage of ERa, ERb and AR 
immunoexpression in the testis, epididymis and seminal 
vesicle of the immunohistochemically stained sections. The 
mean cross-sectional area and the mean germinal epithelium 
height of the seminiferous tubules (STs) were measured. Five 
sections were analyzed for each animal. Five readings from 
each section were measured and the mean for each animal 
was calculated according to Zhou et al. [31]. The morpho-
metric data was presented as per Editor recommendation.
Statistical analysis. Data were analyzed using the Statisti-
cal Package for the Social Sciences (SPSS) version 16. For 
non-parametric data, Analysis of Variance (ANOVA) Kru-
skal-Wallis followed by a post-hoc test (based on the Dunn 
procedure) was used to analyze each pair of groups, thereby 
avoiding a multiple-comparison effect. For the parametric 
data, the different groups were compared using ANOVA 
(f test), followed by a Bonferroni post hoc test. A p value 
less than 0.05 was considered to be significant.
Results
Biochemical findings and body weight changes 
There were no significant differences in glucose le-
vel among the groups at start of the study (data not 
shown). All groups showed significant higher FBS 
and HbA1c compared to that of the NC rats. All drugs 
significantly decreased the FBS and HbA1c compared 
to the DC rats minimally with sitagliptin (Table 1). All 
drugs significantly increased serum insulin compared 
to DC group maximally with metformin (Table 1). TC, 
TG and MDA were significantly higher in all groups 
compared to the NC rats while these parameters were 
significantly lower in the studied drugs compared 
to the DC rats minimally with sitagliptin (Table 1). 
Although testosterone level was significantly reduced 
in the DC compared to the NC group, it increased 
in the metformin-treated group decreased in both 
pioglitazone and sitagliptin-treated groups compared 
to the DC (Table 1).
At the end of the study all rat groups showed 
significantly increased body weight (BW) compared 
to the NC rats and only pioglitazone significantly 
increased BW compared to the DC rats (Table 1). 
Although the weights of the testis, epididymis and 
seminal vesicles were significantly reduced the DC 
compared to the NC group, these weight significantly 
increased in all treated groups compared to the DC. 
In the metformin-treated group the organs’ weights 
showed insignificant difference from the NC group 
(Table 2).
Histological and immunohistochemical findings
Testis
The testis of the DC rats showed irregular seminife-
rous tubules (STs) lined with disorganized germinal 
epithelium and the intervening interstitial connective 
tissue (ICT) appeared edematous compared to the 
NC rats (Figure 1A, B). The STs of metformin-tre-
ated rats were line with more or less intact germinal 
epithelium with few deformed spermatocytes with 
dark nuclei and the ICT was edematous. The same 
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changes were observed in the less affected STs of 
pioglitazone-treated rats while the markedly affected 
tubules were atrophied. Testis of sitagliptin-treated 
rats showed STs with most of the spermatocytes in 
different mitotic stages (Figure 1C, E). There was 
significant reduction in the mean cross-sectional area 
of the SNTs and the germinal epithelium height of 
both pioglitazone- and sitagliptin-treated groups while 
the metformin-treated group showed insignificant 
reduction compared to the NC (Table 3). Although 
the testicular tissue of DC, metformin-, pioglitazone-, 
sitagliptin-treated groups showed an increase in the 
amount of collagen fibers, the area percent of the MT
-stained collagen fibers showed insignificant increase 
compared to the NC group (Figure 1F–K). 
Regards the immunolocalization of estrogen and 
androgen receptors in testicular tissue, the NC group 
showed immunoexpression of ERa in the Leydig cells 
(LC) that was reduced in the untreated diabetic group 
as well metformin-, pioglitazone- and sitagliptin-tre-
ated groups. This reduction was statistically significant 
only in untreated diabetic and pioglitazone-treated 
groups compared to the NC (Figure 2A–F). Control 
testis showed ERb immunoexpression in Sertoli cells 
(SC), spermatogonia, LC and spermatids. The percent 
of ERb-stained area was significantly decreased in the 
DC and pioglitazone-treated groups when compared 
to the NC (Figure 2G–L). Control group showed AR 
immunoexpression in SC, peritubular myoid cells, LC 
and the spermatids (Figure 2M–R).
Epididymis
Corpus of the control epididymis was lined with 
pseudostratified columnar epithelium with stere-
ocilia and surrounded by thin peritubular smooth 
muscle layer. Numerous principal cells, basal cells, 
less apical cells and narrow cells were seen among 
the lining epithelium. Cauda of the control epididy-
mis appeared with wider lumen and surrounded by 
thicker peritubular muscle layer (Figure 3A, B). Both 
epididymal corpus and cauda of the DC, metformin-, 
pioglitazone- and sitagliptin-treated groups showed 
Table 1. Concentration of selected substances and hormones in blood and serum
NC STZ STZ + metformin STZ + pioglitazone STZ + sitagliptin
FBG [mmol/L] 005.73 ± 0.61 20.81 ± 0.9a 012.94 ± 0.7a, b 013.25 ± 2.1a, b 015.79 ± 1.8a, b
HbA1c (%) 04.45 ± 0.3 11.61 ± 0.9
a 007.05 ± 0.9a,b 007.45 ± 0.7a ,b 010.35 ± 0.7a, b
Insulin [pmol/L] 266.90 ± 14.1 241.50 ± 11.5a 287.60 ± 6.8a, b 259.40 ± 6.5a, b 256.90 ± 8.8a, b
Cholesterol [mmol/L] 01.36 ± 0.2 05.09 ± 0.5a 003.15 ± 0.4a, b 003.88 ± 0.7a, b 004.05 ± 0.5a, b
TG [mmol/L] 00.47 ± 0.1 01.97 ± 0.5a 001.39 ± 0.3a, b 001.49 ± 0.2a, b 001.52 ± 0.2a, b
MDA [nmol/mL] 01.64 ± 0.2 11.93 ± 0.5a 005.20 ± 0.5a, b 007.11 ± 0.7a, b 010.74 ± 0.9a, b
Testosterone [ng/mL] 001.4 ± 0.1 000.70 ± 0.04a 0001.13 ± 0.09a, b 000.21 ± 0.2a, b 0000.21 ± 0.05a, b
Data express mean ± standard deviation. asignificantly different from normal control rats (NC); bsignificantly different from diabetic rats (STZ), 
p < 0.05. Abbreviations: NC — normal control group; STZ — rats treated with streptozotocin; FBG — fasting blood glucose; HbA1c — glycated 
hemoglobin; TG — triglycerides; MDA — malondialdehyde
Table 2. Body weight and weight of male reproductive organs of the studied rat groups
Groups
NC STZ STZ + metformin STZ + pioglitazone STZ + sitagliptin
Body weight [g] 258.40 ± 14.9 280.00 ± 12.3a 274.10 ± 7.1a 301.80 ± 12.2a, b 269.90 ± 5.1b
Right testis weight [g] 0001.5 ± 0.09 000.58 ± 0.10a 0001.32 ± 0.05b 0001.2 ± 0.04a, b 00001.14 ± 0.03a, b
Left testis weight [g] 0001.7 ± 0.05 000.60 ± 0.09a 0001.42 ± 0.06b 001.20 ± 0.44a, b 00001.19 ± 0.20a, b
Right epididymis weight [g] 000.36 ± 0.06 000.24 ± 0.01a 0000.31 ± 0.03b 000.21 ± 0.02a, b 00000.18 ± 0.01a, b
Left epididymis weight [g] 000.32 ± 0.01 000.25 ± 0.02a 0000.32 ± 0.02b 000.22 ± 0.01a, b 00000.17 ± 0.01a, b
Right seminal vesicle weight [g] 000.44 ± 0.05 000.23 ± 0.02a 0000.38 ± 0.08b 00.26 ± 0.07a 0000.25 ± 0.02a
Left seminal vesicle weight [g] 000.45 ± 0.06 000.21 ± 0.05a 0000.39 ± 0.08b 00.24 ± 0.07a 0000.23 ± 0.05
Abbreviations as for Table 1. Data express mean ± standard deviation. asignificantly different from normal control rats (NC); bsignificantly diffe-
rent from diabetic rats (STZ), p < 0.05
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Figure 1. A. Normal control rat has intact structure of testis; B. Testis of diabetic rat; C. Testis of diabetic rat treated with 
metformin show deformed primary spermatocytes (arrow) with dark nuclei, few spermatozoa in the lumen (asterisk) and 
edematous interstitial connective tissue with some cellular vacuolization; D. Testis of diabetic rat treated with pioglita-
zone shows atrophied STs (star) while another ST shows deformed spermatocytes with dark nuclei (arrow); E. Testis of 
diabetic rat treated with sitagliptin shows reduced germinal epithelium, many spermatocytes in the mitotic stages (thick 
arrow) and congested capillaries (arrow head) (H & E staining: × 600, insert: × 200); F. Normal control rat testis shows 
minimal collagen fibers (arrow); G. Testis of diabetic rat; H. Testis of diabetic rat treated with metformin or pioglitazone 
(I), or sitagliptin (J) show excess collagen fibers (arrow) (Masson trichrome staining: × 200); K. The area percent of the 
collagen fibers all groups. Abbreviations: NC — normal control rats; DC — diabetic control rats (STZ-induced diabetes); 
H & E — hematoxylin and eosin; ST — seminiferous tubule
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Figure 2. A. Testis of normal control rat shows ERa expression in the interstitial LC; B. Testis of diabetic rat and testis 
of diabetic rat treated with metformin (C), pioglitazone (D) and sitagliptin (E) show markedly reduction (arrow) in ERa 
expression (anti-ERa immunostaining: × 600); F. The area percentage of ERa immunoexpression in testis of all groups; 
G. Testis of normal control rat shows ERb expression in SC (arrow), spermatogonia (arrow head), LC (bi-head arrow) 
and round or elongated spermatid (asterisk); H. Testis of diabetic rat; I. Testis of diabetic rat treated with metformin  
or pioglitazone (J), or sitagliptin (K) show reduction in ERb expression (ERb immunostaining: × 600); L. The area per-
centage of ERb immunoexpression in testis of all rat groups; M. Testis of normal control rat shows AR expression in SC 
(arrow), PMC (arrowhead), LC (bi-head arrow) and round or elongated spermatid (asterisk); N. Testis of diabetic rat;  
O. Testis of diabetic rat treated with metformin or pioglitazone (P), or sitagliptin (Q) show reduction in AR immuno-
expression (anti-AR immunostaining: × 600); R. The area percentage of AR expression in the testis of all groups.  
Note. Inserts show negative control slides. Abbreviations: ERa — estrogen receptor a; LC — Leydig cells; ERb — estrogen 
receptor b; SC — Sertoli cells; AR — androgen receptors; PMC — peritubular myoid cells
A G M
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Figure 3. A. Corpus of epididymis of normal control rat is lined by pseudostratified columnar epithelium with stereocilia 
and numerous principal cells (thick arrows), basal cells (arrow head), less apical cells (thick arrow), narrow cells (bi-head 
arrow) and thin PSM (bifid arrow); B. Cauda of the normal control rat shows wider lumen and thicker PSM (bifid arrow); 
C. Corpus and cauda (D) of epididymis of diabetic rat; E. Corpus and cauda (F) of epididymis of diabetic rat treated with 
metformin show clumping of the nuclei of epithelial cells, cytoplasmic vacuoles (arrow) and disruption of the epididymal 
duct wall (thick arrow) with the leakage of sperms; G. Corpus and cauda (H) of epididymis of diabetic rat treated with 
pioglitazone; I. Corpus and cauda (J) of diabetic rat treated with sitagliptin show epithelial cells with many cytoplasmic 
vacuoles (thin arrow) and dark nuclei (arrowhead) (H & E staining: × 1,000, insert: × 200). Abbreviations: as for Figure 1
A B
C D
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Table 3. Morphometric measurements in male reproductive organs of the studied groups
Parameter Groups 
NC STZ STZ +  
metformin
STZ +  
pioglitazone
STZ +  
sitagliptin
Testis: cross-sectional area of seminiferous  
tubules [× 102 µm2]
144.3 ± 10.6 316.8 ± 15.7a 00177 ± 50.3b 00309 ± 61.2 384.3 ± 28b
Testis: germinal epithelium height [µm] 35.2 ± 2.7 23.1 ± 4.9a 33.9 ± 5.2b 020.5 ± 11.9 020.3 ± 1.9
Corpus of epididymis: epithelium height [µm] 023.3 ± 0.71 012.8 ± 0.72a 0021 ± 1.9b 014.3 ± 0.7b 0016.9 ± 1.3b
Cauda of epididymis: epithelium height [µm] 20.6 ± 1.4 14.1 ± 1.2a 16.3 ± 2.4b 13.1 ± 0.7 013.5 ± 1.5
Abbreviations as for Table 1. Data express mean ± standard deviation. asignificantly different from normal control rats (NC); bsignificantly  
different from diabetic rats (STZ), p < 0.05
some epithelial cells with dark nuclei while other cells 
showed cytoplasmic vacuoles. The DC and metformin
-treated groups showed clumping of the nuclei of the 
epithelial lining. The metformin-treated group sho-
wed disruption of many ducts of the epididymal corpus 
with leakage of sperms outside the duct (Figure 3C–J). 
There was significant reduction in the epithelial cell 
height of both corpus and cauda of epididymis of all 
treated groups compared to the NC (Table 3).
Corpus and cauda of the control epididymis sho-
wed strong to moderate ERb immunoexpression in 
the principal cells of the lining epithelium, sperm, 
interstitial cells and the peritubular smooth muscles 
(Figure 4A, B). The DC group showed moderate to 
weak ERb expression. Metformin-, pioglitazone- and 
sitagliptin-treated groups showed marked decrease 
in ERb expression in the epithelium and peritubular 
muscle while the interstitial cells and sperm still sho-
wed positive ERb expression. There was significant 
decrease in the area percent of ERb expression in both 
corpus and cauda of the epididymis of the DC group 
as well as pioglitazone- and sitagliptin-treated groups 
compared to the NC (Figure 4C–L). Corpus and cau-
da of the control epididymis showed strong nuclear 
AR expression in the lining epithelium, sperm and 
interstitial cells while the peri-tubular smooth muscles 
appeared negative (Figure 5A, B). The DC group as 
well as all the treated groups showed moderate to 
weak cytoplasmic AR expression in epithelial cells of 
corpus and cauda while the interstitial cells still show 
positive expression. Statistical analysis showed signi-
ficant decrease in the area percent of AR expression 
in the corpus of the DC and pioglitazone- and sita-
gliptin-treated groups and significant decrease in the 
cauda of the DC compared to the NC (Figure 5C–L).
Seminal vesicles
Seminal vesicle of the DC group showed disorganized 
epithelium and increased intraepithelial lymphocytes 
compared to the NC (Figure 6A, B). Similar chan-
ges were observed in metformin-, pioglitazone- and 
sitagliptin-treated groups with evident degree in 
sitagliptin-treated group (Figure 6C–E). Control se-
minal vesicle showed ERb immunoexpression in the 
epithelial cells and the smooth muscle fibers (SMF). 
The DC, pioglitazone and sitagliptin-treated groups 
group showed week expression in few epithelial cells 
and negative expression in SMF while metformin-tre-
ated group showed few epithelial cells with strong 
ERb expression. There was significant decrease in the 
area percent of ERb expression of the DC, pioglita-
zone- and sitagliptin-treated groups compared to the 
NC (Figure 6F–K). Control seminal vesicle showed 
moderate AR immunoexpression in the epithelial 
cells and negative expression in the SMF while the DC 
group showed negative expression in both epithelium 
and SMF. Metformin-, pioglitazone- and sitagliptin
-treated groups showed week AR immunoexpression 
in the epithelial cells. There was significant decrease 
in the area percent of AR expression in the seminal 
vesicle of the DC, pioglitazone- and sitagliptin-treated 
groups compared to the NC and significant decrease 
in pioglitazone- and sitagliptin-treated groups com-
pared to the DC (Figure 6L–Q).
Discussion
Estrogens are essential to preserve the structural 
and functional integrity of the male reproductive 
tract and their a-receptors are necessary for male 
fertility [32]. Structural changes of the reproductive 
system in DM have been reported in several studies 
[33–35] while little ones dealt with the effect of the 
different antidiabetic drugs on the structure of such 
system. This study aimed to evaluate the effects of 
the commonly used oral antidiabetics; metformin, 
pioglitazone and sitagliptin on the structure of male 
reproductive system in a STZ-induced diabetic rats. 
It was observed that the therapies studied in this work 
succeeded in controlling the STZ-induced diabetic 
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Figure 4. Epididymal corpus (A) and cauda (B) of normal control rat show strong to moderate ERb expression mainly in 
the principal cells (arrows), sperm (arrowhead), interstitial cells (curved arrow) and the PSM (bi-head arrow); C. Corpus 
and cauda (D) of diabetic rat show moderate to weak ERb expression (arrow); E. Corpus and cauda (F) of diabetic rat 
treated with metformin or pioglitazone (G and H, respectively), or sitagliptin (I and J, respectively) show decreased ERb 
expression in epithelium (arrow) and PSM (bi-head) while interstitial cells and sperm show strong expression (arrow)  
(anti-ERb immunostaining: × 1,000); K, L. The area percentage of ERb expression in both corpus and cauda, respectively, 
in all rat groups. Abbreviations: as for Figure 2
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Figure 5. Epididymal corpus (A) and cauda (B) of the normal control rat show strong AR expression in the nuclei of the 
lining epithelium (arrow) and interstitial cells (curved arrow), while the PSM (bi-head arrow) appear negative; C. Corpus 
and cauda (D) of diabetic rat; E. Corpus and cauda (F) of diabetic rat treated with metformin or pioglitazone (G and H, 
respectively), or sitagliptin (I and J, respectively) show moderate to weak AR expression (arrow) of corpus and cauda 
while the interstitial cells (curved arrow) also show positive expression (anti-AR immunostaining: × 1,000); K. The area 
percentage of AR immunoexpression in the corpus and cauda (L) of epididymis in all rat groups. Note. Inserts show  
negative control slides. Abbreviations: as for Figure 2
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Figure 6. A. Seminal vesicle of normal control rat show intact columnar epithelium (arrow); B. Seminal vesicle of diabetic 
rat or diabetic rat treated with metformin (C), or pioglitazone (D), or sitagliptin (E) show disorganized epithelium with 
intraepithelial lymphocytes (arrow) and dark nuclei (bi-head arrow) (H & E: × 600); F. Seminal vesicle of normal control 
rat shows strong to moderate (arrow) and week (asterisk) ERb expression in epithelial cells and SMF, respectively;  
G. Seminal vesicle of diabetic rat and diabetic rat treated with metformin (H) or pioglitazone (I), or sitagliptin (J) show 
week expression in few epithelial cells and negative expression in SMF (anti-ERb immunostaining: × 1,000); L. Seminal  
vesicle of normal control rat shows strong AR expression (arrow) in epithelial cells while SMF show no expression  
(asterisk); M. Seminal vesicle of diabetic rat shows no AR expression in the epithelium (arrowhead); N. Seminal vesicle of 
diabetic rat treated with metformin or pioglitazone (O), or sitagliptin (P) show moderate expression in the epithelial cells 
(arrow) (anti-AR immunostaining: × 1,000); K. The area percentage of ERb and AR (Q) expression in the seminal  
vesicle of all rat groups. Note. Inserts show negative control slides. Abbreviations: as for Figure 2; SMF — smooth muscle fibers
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by reducing hyperglycemia, HbA1c, TC, TGs, MDA, 
and partially prevented insulinopenia. These results 
are consistent with the previous studies on metfor- 
min [24], pioglitazone [23] and sitagliptin [36, 37].
Although the weights of testis, epididymis and 
seminal vesicle as well as testosterone hormone level 
was significantly reduced in the STZ-induced diabetic 
rats and these findings were consistent with those of 
previous studies [38–41], metformin succeeded to 
restore it back to values with insignificant difference 
compared to the NC group while the pioglitazone and 
sitagliptin failed to do that. Reduced serum testoste-
rone in diabetic rats was attributed in previous studies 
to neuroendocrine dysfunction and the absence of the 
stimulatory effect of insulin on the LC [3, 42]. 
The disorganized germinal epithelium and edema-
tous thickened interstitial connective tissue in the tes-
tis of diabetic rats have been described in the previous 
studies [33, 40, 42–44] and have been also observed 
in this study. The crowded nuclei and cytoplasmic 
vacuoles of the epithelial lining the epididymis of 
the DC observed in this study was in agreement with 
those of Soudamani et al. [45] who attributed them 
to shrinkage of epididymal tubules. 
Among the main findings in this study that metfor-
min has induced the least pathologic changes on the 
structure of the testis and this is in line with the finding 
of Kianifard et al. [46] and is supported by the recent 
results of Alves et al. [13] which suggest that metfor-
min may improve the male reproductive potential 
and it is, therefore, a suitable anti-diabetic agent for 
young adults and adolescents with T2D, as it will not 
severely compromise their reproductive function. On 
the other hand, these results were in contradict with 
those of Adaramoye et al. [47] who reported marked 
histological alterations concomitant with a decrease in 
sperm counts and motility in healthy adult male rats, 
which were administered metformin, for three conse-
cutive weeks. These reproductive deleterious results 
could be attributed to having available lower levels of 
glucose due to the oral antidiabetic metformin which 
invalidate their results obtained. Pioglitazone- and 
sitagliptin-treated rats showed markedly histopatho-
logic changes in testis, epididymis and seminal vesicle 
compared to those treated with metformin and un-
fortunately, no studies dealt with their effect on the 
structure of the testis were available to be compared 
with these results. When it came to the mechanism 
by which the drugs induced these changes, lipid 
peroxidation has been suggested as one of the mo-
lecular mechanisms involved in drug-induced tissue 
injuries [48]. In the present study, increased levels of 
MDA, an index of lipid peroxidation, were observed 
in the serum of all treated rats however metformin 
remains the least drug caused this effect. This may 
be due in part to radical species generated during 
metabolism of drugs which attack cell membrane 
phospholipids and other circulating lipids. 
Testicular immunoexpression of ERa [28, 29, 49], 
ERb and AR [50, 51] as well as seminal vesicle ERb 
and AR immunoexpression [30, 52] and epididymal 
ERb [31, 53] immunoexpression were all previously 
described and are consistent with what described in 
this study. A significant reduction in testicular ERb 
and ERb expression in pioglitazone-treated group as 
well as in epididymal and seminal vesicle ERb and 
AR expression in pioglitazone- and sitagliptin-treated 
groups were observed compared to the NC. These 
findings indicate that metformin has the least effect, 
among the studied drugs, on the estrogens and andro-
gens receptors. It was observed that the DC as well 
as all the treated groups showed cytoplasmic instead 
of nuclear AR expression. This finding could be ex- 
plained in the light of the previous studies reported 
that, in the presence of androgens, AR is normally 
localized in the nucleus while in the absence of an-
drogens the receptor migrates from the nucleus back 
into the cytoplasm [54–56]. Therefore, alterations 
in normal AR expression in these cells would be an 
indicator of the hormonal status of the cells [53]. 
In conclusion, the present study showed different 
grades of histopathological changes observed in the 
male reproductive system of type 2 diabetic rats 
treated with metformin, pioglitazone and sitagliptin. 
The histological structure as well estrogen and an-
drogen receptors expression in the system organs 
were negatively affected with all studied antidiabetic 
drugs with the maximal impact of pioglitazone then 
sitagliptin. Metformin had the least negative effect on 
the structure of the reproductive organs. The results 
of this experimental study suggest that pioglitazone 
and sitagliptin should be avoided in the treatment of 
young male diabetic patients. 
Acknowledgments
This work was funded by the Deanship of Scientific 
Research, (DSR), King Abdulaziz University (KAU), 
Jeddah, grant number 140-001-D1434. The authors, 
therefore, acknowledge with thanks DSR technical 
and financial support.
References
1. Harold E. Sick fat, metabolic disease, and atherosclerosis. Am 
J Med. 2009;122(suppl):S26–S37. doi: 10.1016/j.amjmed.2008.10.015.
2. Aktas C, Kanterb M, Erboðab M et al. Effects of experimental 
diabetes on testis proliferations and apoptosis in rats. J Exp 
Clin Med. 2011;28:94–98. doi: 10.5835/jecm.omu.28.03.001.
47Effect of oral antidiabetics on histology of male reproductive system in rats
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0005
www.fhc.viamedica.pl
3. Ballester J, Carmen Munoz M, Dominguez J et al. Insulin-
-dependent diabetes affect testicular function by FSH- and 
LH-linked mechanisms. J Androl. 2004;25:706–719. PMID: 
15292100.
4. Kuhn-Velten N, Waldenburger D, Staib W. Evaluation of ste-
roid biosynthetic lesions in isolated Leydig cells from the testes 
of streptozotocin-diabetic rats. Diabetol. 1982;23:529–533. 
PMID: 6295863.
5. Morimoto S, Mendoza-Rodriguez CA, Hiriat M et al. 
Protective effect of testosterone on early apoptotic damage 
induced by streptozotocin in rat pancreas. J Endocrinol. 
2005;187:217–224. PMID: 16293769.
6. Hamilton E, Ventura SJ. Fertility and abortion rates in the 
United States, 1960–2002. Int J Androl. 2006;29:34–45. PMID: 
16466522.
7. Lutz W. Fertility rates and future population trends: will Eu-
rope’s birth rate recover or continue to decline? Int J Androl. 
2006;29:25–33. PMID: 16466521.
8. Alves MG, Martins AD, Rato L et al. Molecular mechanisms 
beyond glucose transport in diabetes-related male infertility. 
Biochim Biophys Acta. 2013;1832:626–635. doi: 10.1016/ 
/j.bbadis.2013.01.011.
9. Maric C, Forsblom C, Thorn L et al. Association between 
testosterone, estradiol and sex hormone binding globulin 
levels in men with type 1 diabetes with nephropathy. Steroids. 
2010;75:772–778. doi: 10.1016/j.steroids.2010.01.011.
10. Stanworth RD, Kapoor D, Channer KS et al. Dyslipidaemia 
is associated with testosterone, oestradiol and androgen 
receptor CAG repeat polymorphism in men with type 2 dia- 
betes. Clin Endocrinol. 2011;74:624–630. doi: 10.1111/j.
1365-2265.2011.03969.x.
11. Rossetti L, De Fronzo RA, Gharezi R et al. Effect of metfor-
min treatment on insulin action in diabetic rats: in vivo and 
in vitro correlations. Metabolism. 1990;39:425–435. PMID: 
2157941.
12. Bailey CJ, Turner RC. Metformin. New Engl J Med. 
1996;334:574–579. PMID: 8569826.
13. Alves MG, Martins AD, Vaz CV et al. Metformin and male 
reproduction: effects on Sertoli cell metabolism. Br J Pharma-
col. 2014;171:1033–1042. doi: 10.1111/bph.12522.
14. Engel SS, Round E, Golm GT et al. Safety and tolerability 
of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical 
studies. Diab Ther. 2013;4:119–145. doi: 10.1007/s13300-013-
-0031-1.
15. Ding SY, Shen ZF, Chen YT et al. Pioglitazone can amelio-
rate insulin resistance in low-dose streptozotocin and high 
sucrose-fat diet induced obese rats. Acta Pharmacol Sin. 
2005;26:575–580. PMID: 15842776.
16. Suter SL, Nolan JJ, Wallace P et al. Metabolic effects of new 
oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes 
Care. 1992;15:193–203. PMID: 1547676.
17. Patrão MTCC, Silva EJR, Avellar MCW. Androgens and 
the male reproductive tract: an overview of classical ro-
les and current perspectives. Arq Bras Endocrinol Metab. 
2009;53:934–945. PMID: 20126845.
18. Bremner WJ, Millar MR, Sharpe RM et al. Immunohisto-
chemical localization of androgen receptors in the rat testis: 
evidence for stage-dependent expression and regulation 
by androgens. Endocrinol. 1994;135:1227–1234. PMID: 
8070367.
19. Dupont S, Krust A, Gansmuller A et al. Effect of single and 
compound knockouts of estrogen receptors a (ER a) and b 
(ER b) on mouse reproductive phenotypes. Development. 
2000;127:4277–4291. PMID: 10976058.
20. Hess RA. Estrogen in the adult male reproductive tract: 
a review. Rep Biol Endocrinol. 2003;1:52. PMID: 12904263.
21. Manisha M, Priyanjali D, Jayant L et al. Indian herbs and her-
bal drugs used for the treatment of diabetes. J Clin Biochem 
Nutr. 2007;40:163–173. doi: 10.3164/jcbn.40.163.
22. Tatarkiewicz K, Smith PA, Sablan EJ et al. Exenatide does 
not evoke pancreatitis and attenuates chemically induced 
pancreatitis in normal and diabetic rodents. Am J Physiol 
Endocrinol Metab. 2010;299:E1076–E1086. doi: 10.1152/ 
/ajpendo.00479.2010.
23. Srinivasan K, Viswanad B, Asrat L et al. Combination of 
high-fat diet-fed and low-dose streptozotocin-treated rat: 
a model for type 2 diabetes and pharmacological screening. 
Pharmacol Res. 2005;52:313–320. PMID: 15979893.
24. Sun X, Han F, Yi J et al. Effect of aspirin on the expression of 
hepatocyte NF-kB and serum TNF-a in streptozotocin-indu-
ced type 2 diabetic rats. J Korean Med Sci. 2011;26:765–770. 
doi: 10.3346/jkms.2011.26.6.765.
25. Chen B, Moore A, Escobedo LV et al. Sitagliptin lowers 
glucagon and improves glucose tolerance in prediabetic obese 
SHROB rats. Exp Biol Med. 2011;236:309–314. doi: 10.1258/ 
/ebm.2010.010161.
26. Ferreira L, Teixeira-de-Lemos E, Pinto F et al. Effects of 
sitagliptin treatment on dysmetabolism, inflammation, and 
oxidative stress in an animal model of type 2 diabetes (ZDF 
Rat). Med Inflam. 2010;1–11. doi: 10.1155/2010/592760.
27. Drury RAB, Wallington EA. Carleton’s histological technique. 
5th ed. Oxford New York: Oxford University Press; 1980.
28. Nie R, Zhou Q, Jassim E et al. Differential expression of 
estrogen receptors a & b in the reproductive tract of the 
adult male dog and cat. Biol Reprod. 2002;66:1161–1168. doi: 
10.1095/biolreprod66.4.1161.
29. Attia GM, Elmansy RA. Localization of estrogen receptor a in 
adult male albino rat reproductive tract: an immunohistoche-
mical study. Egyp J Histol. 2013;36:494–504. doi: 10.1097/01.
EHX.0000429820.80262.ed.
30. Saunders PTK, Sharpe RM, Williams K et al. Differential 
expression of estrogen receptor a and b proteins in the testes 
and male reproductive system of human and non-human pri-
mates. Mol Hum Reprod. 2001;7:227–236. PMID: 11228242.
31. Zhou Q, Nie R, Prins G et al. Localization of androgen and 
estrogen receptors in adult male mouse reproductive tract. 
J Androl. 2002;23:870–881. PMID: 12399534.
32. Rochira V, Granata ARM, Madeo B et al. Estrogens in males: 
what have we learned in the last 10 years? Asian J Androl. 
2005;7:3–20. PMID: 15685347.
33. Cai L, Chen S, Evans T et al. Apoptotic germ-cell death and 
testicular damage in experimental diabetes: prevention by endo-
thelin antagonism. Urol Res. 2000;28:342–347. PMID: 11127715.
34. Sanguinetti RE, Ogawa K, Kurohmaru M et al. Ultra-stru- 
ctural changes in mouse Leydig cells after streptozotocin 
administration. Exp Anim. 1995;44:71–73. PMID: 7705483.
35. Ozturk F, Gul M, Agkadir M et al. Histological alterations 
of rat testes in experimental diabetes. T Kin J Med Sci. 
2002;22:173–178.
36. Mu J, Petrov A, Eiermann GJ et al. Inhibition of DPP-4 
with sitagliptin improves glycemic control and restores 
islet cell mass and function in a rodent model of type 2 dia- 
betes. Eur J Pharmacol. 2009;25:148–154. doi: 10.1016/ 
/j.ejphar.2009.09.027.
37. Yeom JA, Kim ES, Park HS et al. Both sitagliptin analogue 
& pioglitazone preserve the beta-cell proportion in the 
islets with different mechanism in non-obese and obese 
diabetic mice. BMB Rep. 2011;44:713–718. doi: 10.5483/ 
/BMBRep.2011.44.11.713.
48 Nasra N. Ayuob et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0005
www.fhc.viamedica.pl
38. Soudamani S, Malini T, Balasubramanian K. Effects of strep-
tozotocin-diabetes and insulin replacement on the epididymis 
of prepubertal rats: histological and histomorphometric stu-
dies. Endocr Res. 2005;31:81–98. PMID: 16353669.
39. Scarano WR, Messias AG, Oliva SU et al. Sexual behavior, 
sperm quantity and quality after short-term streptozotocin-in-
duced hyperglycaemia in rats. Int J Androl. 2006;29:482–488. 
PMID: 16524366.
40. Jelodar G, Khaksar Z, Pourahmadi M. Endocrine proﬁle 
and testicular histomorphometry in adult rat offspring of 
diabetic mothers. J Physiol Sci. 2009;59:377–382. doi: 10.1007/ 
/s12576-009-0045-7.
41. Tsounapi P, Saito M, Dimitriadis F et al. Antioxidant treat-
ment with edaravone or taurine ameliorates diabetes-in-
duced testicular dysfunction in the rat. Mol Cell Biochem. 
2012;369:195–204. doi: 10.1007/s11010-012-1382-z.
42. Hassan G, Abdel Moneium T. Structural changes in the testes 
of streptozotocin-induced diabetic rats. Suez Canal Univ Med J. 
2001;4:17–25.
43. Hikim S, Swerdloff RS. Hormonal and genetic control of 
germ cell apoptosis in the testis. Rev Reprod. 1999;4:38–47. 
PMID: 10051101.
44. Gunelia E, Tugyanb H, Ozturke M et al. Effect of melatonin 
on testicular damage in streptozotocin-induced diabetes rats. 
Eur Surg Res. 2008;40:354–360. doi: 10.1159/000118032.
45. Soudamani S, Yuvaraj S, Malini T et al. Experimental diabetes 
has adverse effects on the differentiation of ventral prostate 
during sexual maturation of rats. Anat Rec A Discov Mol Cell 
Evol Biol. 2005;287:1281–1289. PMID: 16237732.
46. Kianifard D, Sadrkhanlou RA, Hasanzadeh S. The histo- 
logical, histomorphometrical and histochemical changes 
of testicular tissue in the metformin treated and untreated 
streptozotocin-induced adult diabetic rats. Vet Res Forum. 
2011;2:13–24.
47. Adaramoye O, Akanni O, Adesanoye O, Labo-Popoola O, 
Olaremi O. Evaluation of toxic effects of metformin hydro-
chloride and glibenclamide on some organs of male rats. Nig 
J Phys Sci. 2013;27:137–144. PMID: 23652227.
48. Jeng, HA, Pan, CH, Diawara N et al. Polycyclic aromatic 
hydrocarboninduced oxidative stress and lipid peroxidation 
in relation to immunological alteration. Occup Environ Med. 
2011;68:653–658. doi: 10.1136/oem.2010.055020.
49. Sar M, Welsch F. Estrogen receptor alpha and beta in rat prostate 
and epididymis. Andrologia. 2000;32:295–301. PMID: 11021522.
50. Bilińska B, Schmalz-Frączek B, Kotula M et al. Photoperiod
-dependent capability of androgen aromatization and the role 
of estrogens in the bank vole testis visualized by means of im-
munohistochemistry. Mol Cell Endocrinol. 2001;178:189–198. 
PMID: 11403909.
51. Gancarczyk M, Kuklińska M, Sadowska J et al. Aromatization 
and antioxidant capacity in the testis of seasonally breeding 
bank voles. Effects of LH, PRL and IGF-1. Theriogenology. 
2006;65:1376–1391. PMID: 16226304.
52. Fisher JS, Millar MR, Majdic G et al. Immunolocalization 
of estrogen receptors-alpha within the testis and excurrent 
ducts of the rat and marmoset monkey from perinatal life to 
adulthood. J Endocrinol. 1997;153:485–495. PMID: 9204003.
53. Zaya R, Hennick C, Pearl CA. In vitro expression of androgen and 
estrogen receptors in prepubertal and adult rat epididymis. Gen 
Comp Endocrinol. 2012;178:573e. doi: 10.1016/j.ygcen.2012.07.004.
54. Tyagi RK, Lavrovsky Y, Ahn SC et al. Dynamics of intracellu-
lar movement and nucleocytoplasmic recycling of the ligand- 
-activated androgen receptor in living cells. Mol Endocrinol. 
2000;14:1162–1174. PMID: 10935541.
55. Zhu LJ, Hardy MP, Inigo IV et al. Effects of androgen on 
androgen receptor expression in rat testicular and epididymal 
cells: a quantitative immunohistochemical study. Biol Reprod. 
2000;63:368–376. PMID: 10906039.
56. Trybek G, Kolasa AM, Marchlewicz L et al. Immunoloca-
lization of androgen receptor in the epididymis of rats with 
dihydrotestosterone deﬁciency. Reprod Biol. 2005;5:291–301. 
PMID: 16372046.
Submitted: 16 October, 2014 
Accepted after reviews: 9 March, 2015 
Available as AoP: 12 March, 2015
